BD and AlleCure link up on allergies tests:
This article was originally published in Clinica
Executive Summary
BD Biosciences, a division of Becton Dickinson, is to develop assays to support treatments for allergies and autoimmune diseases made by biopharmaceutical firm AlleCure. The two firms will jointly focus on developing laboratory tests for use with AlleCure's allergy vaccine technologies. The tests, which will be designed for research and clinical use, are expected to improve the identification of patients with specific allergies and to monitor how well the vaccines are working.